Online training for care teams & individuals

Explore Learn to Care

Find your next step in care.

Your cart

Review your selected training

Methadone and Buprenorphine: Controlled Medicine Safety and Support

Methadone and buprenorphine training | opioid safety course

  • Code: MBSC06
Methadone and buprenorphine training for care workers. Build safer dosing, monitoring and emergency response skills in this opioid safety course

Original price was: $199.Current price is: $99.

Share course:

Facebook
Email
WhatsApp
X
LinkedIn
Reddit
  • Duration Approx. 90 Minutes
  • Languages: English
  • Delivery: 100% online (mobile + desktop)
  • Certificate: Instant digital certificate on completion
  • Email us at: info@learntocare.com.au
  • Course renewal:
    6 months
  • Course Fees: $AUD $199 Original price was: $199.$99Current price is: $99.
Watch the course preview

Methadone and Buprenorphine: Controlled Medicine Safety and Support

Online methadone and buprenorphine training for safer care

This methadone and buprenorphine training gives support workers, care teams and health professionals practical guidance for supporting people who receive these medicines. It covers methadone, buprenorphine, buprenorphine/naloxone, sublingual products, long-acting injectable buprenorphine and transdermal buprenorphine. The course focuses on real risks workers may encounter: medication and identity checks, supervised dosing arrangements, missed doses, secure access, sedation, respiratory depression, medicine interactions, withdrawal, suspected diversion and continuity of treatment. It reinforces one critical rule: workers should never change, replace or “make up” a dose outside the person’s authorised medication plan and their own scope of practice. This online opioid safety course also addresses stigma, privacy and respectful support. It does not assume that a person receiving methadone or buprenorphine has a history of illicit drug use. The indication, treatment plan and individual circumstances matter.

3. Why take this course?

Why methadone and buprenorphine training matters

  • Reduce medication risk by helping workers recognise missed-dose issues, sedation, respiratory concerns and situations requiring escalation.
  • Build worker confidence around different methadone and buprenorphine formulations without encouraging workers to act outside their role or medication authority.
  • Improve emergency response by recognising possible opioid overdose and understanding when naloxone and urgent medical assistance may be required.
  • Support safer provider systems with clearer expectations around storage, controlled access, documentation, incidents and treatment continuity.
  • Strengthen audit evidence by giving providers structured medication safety training that supports relevant NDIS Practice Standards and Aged Care Quality Standards.
  • Improve person-centred care by reducing stigma and supporting confidentiality, dignity and respectful communication.
Opioids can cause sedation and potentially life-threatening respiratory depression, with additional risk where alcohol, benzodiazepines or other central nervous system depressants are involved. Current Australian medicine information also reinforces the importance of monitoring and appropriate clinical oversight.

4. What you’ll gain

Practical opioid medicine safety skills

By completing this controlled medicine safety training, you will be better able to:
  • Identify the differences between methadone, buprenorphine, buprenorphine/naloxone and common treatment formulations.
  • Check the person, medicine, formulation and authorised medication information before providing support.
  • Follow safe processes when a dose is missed, refused, delayed or cannot be verified.
  • Recognise concerning sedation, reduced responsiveness and signs of respiratory depression.
  • Identify risks involving alcohol, benzodiazepines, other opioids and other sedating medicines.
  • Recognise possible withdrawal and escalate changes rather than independently altering treatment.
  • Respond more confidently to suspected opioid overdose, including emergency escalation and naloxone awareness.
  • Document concerns and communicate clearly with supervisors, nurses, prescribers, pharmacists and treatment teams.

5. Who’s it for?

Opioid medicine training for workers, clinicians and provider teams

This methadone and buprenorphine course suits individuals and organisations supporting people who receive opioid medicines in disability, aged care, community care or allied health settings.
  • Disability and NDIS support workers
  • Aged care and community care workers
  • Team leaders and service managers
  • Support coordinators and care coordinators
  • Registered and enrolled nurses
  • Allied health professionals
  • Workers with medication support responsibilities
  • Provider managers responsible for medication safety, training and quality systems
The course is suitable for individual professional development or organisation-wide workforce training.

6. What’s included?

Online controlled medicine safety training

  • Short, practical online video lessons
  • Four modules covering medicine types, safe dosing support, respiratory risk, respectful care and emergencies
  • Scenario-based learning involving missed doses, sedation, suspected diversion, treatment transitions and emergency escalation
  • Knowledge checks and online quizzes
  • Downloadable resources and practical reference material
  • Certificate of Completion – Methadone and Buprenorphine: Controlled Medicine Safety and Support
  • Learner access through the Learn to Care online dashboard
  • Team tracking and completion records for eligible provider accounts
  • Public online certificate verification

7. Which Practice Standards does this course align to?

This course supports relevant medication safety, risk, workforce and person-centred practice requirements. Training completion alone does not demonstrate full regulatory compliance, clinical competency or authorisation to administer medication. Providers must also maintain appropriate policies, procedures, supervision, competency assessment and state or territory medication requirements.

NDIS Practice Standards

  • Management of Medication – Provision of Supports Environment: Supports workers to recognise medication risks, follow authorised medication information, understand potential effects and side effects, maintain safe access and respond appropriately to medication incidents. The NDIS Practice Standards specifically require safe storage and access and expect workers responsible for medication administration to understand effects, side effects and incident responses.
  • Risk Management – Provider Governance and Operational Management: Supports identification and escalation of risks such as sedation, respiratory depression, medicine interactions, missed doses and continuity failures.
  • Incident Management – Provider Governance and Operational Management: Reinforces recognition, escalation, documentation and review of medication-related incidents and emergencies.
  • Responsive Support Provision – Provision of Supports: Supports competent, appropriate and person-centred care, including communication with healthcare and allied health providers where required.
  • Transitions to or from a Provider – Provision of Supports: Supports continuity when a person changes services, enters hospital or returns home, with risks identified, communicated and managed.
  • Privacy and Dignity – Rights and Responsibilities: Supports confidential, respectful care that avoids stigma and protects the person’s privacy and dignity.

Strengthened Aged Care Quality Standards

The following alignment uses the strengthened Aged Care Quality Standards that have applied since 1 November 2025.
  • Standard 1 – The Individual, Outcome 1.2: Dignity, respect and privacy: Supports non-stigmatising care, confidentiality and respectful communication about opioid dependence treatment and pain management.
  • Standard 2 – The Organisation, Outcome 2.4: Risk management: Helps workers and providers recognise and respond to medicine-related risks before harm occurs.
  • Standard 2 – The Organisation, Outcome 2.5: Incident management: Supports appropriate escalation and documentation where medication errors, overdose concerns or other incidents occur.
  • Standard 2 – The Organisation, Outcome 2.9: Human resource management: Supports provider training systems aimed at giving workers the skills and competencies required for their roles and maintaining evidence of completed training.
  • Standard 3 – The Care and Services, Outcomes 3.3 and 3.4: Communicating for safety and quality / Planning and coordination: Supports clear communication and continuity when people move between care services, hospitals, health professionals and home.
  • Standard 5 – Clinical Care, Outcome 5.3: Safe and quality use of medicines: Directly supports medication safety, appropriate worker training, documentation, escalation and safe medication management systems.

8. FAQ

Is the methadone and buprenorphine training online and self-paced?

Yes. The course is completed online and is designed so workers can progress through the video lessons and quizzes at their own pace.

Do I receive a certificate after completing the opioid safety course?

Yes. Successful completion provides a Certificate of Completion – Methadone and Buprenorphine: Controlled Medicine Safety and Support. Learn to Care certificates can also be checked through the online certificate verification system.

Is this course suitable for NDIS and aged care provider teams?

Yes. The course can be used for individual learning or as part of provider workforce training. It is particularly relevant where workers support people receiving methadone, buprenorphine or other opioid medicines.

How long will I have access to the course?

Access is provided according to the individual enrolment, training package or organisation licence attached to your account. Check the access period shown when enrolling or within your Learn to Care account.

Does methadone and buprenorphine training count as CPD?

The course can support relevant professional development and may be recorded as CPD where it meets the requirements of your employer, registration or professional body. Always check the CPD requirements that apply to your role.

How does this course help with audits and compliance?

It gives providers structured evidence that workers have completed training covering medication safety, risk recognition, escalation, incidents, confidentiality and continuity of care. It supports relevant NDIS and strengthened Aged Care Quality Standards, but should sit alongside your organisation’s policies, supervision, competency processes and medication records.

Does this opioid safety course authorise a support worker to administer methadone or buprenorphine?

No. Completing the course does not expand a worker’s scope of practice or automatically authorise medication administration. Workers must follow the person’s authorised medication plan, organisation procedures, professional scope and applicable state or territory requirements.

Does the course only cover opioid dependence treatment?

No. The course deliberately distinguishes between different treatment contexts. Methadone and buprenorphine may appear in opioid dependence treatment and pain-care settings, so workers are taught to check the prescribed indication and treatment plan rather than make assumptions about the person receiving the medicine.

Are you an NDIS or aged care provider?

Stop paying the seat tax!

Train your whole team with just one membership. Unlimited seats. No Cap! Audit-ready, Instant certificates and 1,200 (video) learning modules. 100% Online.

Buy Singular course:

Original price was: $199.Current price is: $99.

Resources

Related Resources